For most people with narcolepsy, management plans require implementation of ongoing pharmacological therapy to keep symptoms under control. Patients may also need substantial lifestyle adjustments, such as maintaining nocturnal sleep hygiene and regular scheduling of daytime naps.
/PRNewswire/ As reported in the Lancet Neurology, daridorexant is the first insomnia medication to demonstrate an effect of a drug therapy to improve both.
The Lancet Neurology reports impact of daridorexant on both nighttime symptoms and daytime functioning in adults with insomnia As reported in the Lancet.